Global Eliquis (Apixaban) Market By Indication (Atrial Fibrillation (AF), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Post-Operative Venous Thromboembolism (VTE) Prophylaxis, Others), By Form (Tablet, Capsule), By Route of Administration (Oral, Nasogastric (NG) Tube), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Aug 2025
- Report ID: 155030
- Number of Pages: 221
- Format:
-
-
-
- Bristol-Myers Squibb Company
- Hoffmann-La Roche Ltd.
- Teva Pharmaceutical Industries Ltd. Company Profile
- Mylan NV
- Pfizer Inc Company Profile
- Sanofi Company Profile
- AstraZeneca Plc Company Profile
- Novartis AG Company Profile
- Johnson & Johnson Private Limited
- GSK plc
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible